NCT03746873

Brief Summary

This study evaluates the effects of the COPD Web (KOLwebben), an interactive web-based tool directed towards people with chronic obstructive pulmonary disease (COPD). The COPD Web include tools that improve health literacy with a specific focus on 1) increased physical activity and 2) use of appropriate self-management strategies. This randomized clinical trial aims to generate evidence on the effect and usability of the COPD Web in a properly powered cohort of patients in primary care context.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
146

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 15, 2018

Completed
Same day until next milestone

Study Start

First participant enrolled

November 15, 2018

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 20, 2018

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 8, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 8, 2022

Completed
Last Updated

December 8, 2023

Status Verified

December 1, 2023

Enrollment Period

3.6 years

First QC Date

November 15, 2018

Last Update Submit

December 7, 2023

Conditions

Keywords

Pulmonary Disease, Chronic ObstructiveHealth promotion toolSelf managementEvidence based careImplementation

Outcome Measures

Primary Outcomes (1)

  • Change in level of objectively measured physical activity

    Level of physical activity will be objectively measured with an activity monitor, the DynaPort MiniMod. The activity monitor data collected during 7 Days at baseline and 7 Days 3- and 12- months after baseline will be used to assess change in level of physical activity.

    7 Days at baseline, 7 days at 3- and 12- months after baseline

Secondary Outcomes (5)

  • Change in level of subjectively assessed physical activity

    7 Days at baseline, 7 days at 3- and 12- months after baseline

  • Change in subjectively assessed dyspnea severity

    7 Days at baseline, 7 days at 3- and 12- months after baseline

  • Change in subjectively assessed COPD-related symptoms

    7 Days at baseline, 7 days at 3- and 12- months after baseline

  • Change in subjectively assessed health related quality of life

    7 Days at baseline, 7 days at 3- and 12- months after baseline

  • Change in health economics using subjectively assessed EQ-5D in combination with self-reported health care contacts

    7 Days at baseline, 7 days at 3- and 12- months after baseline

Other Outcomes (1)

  • Enablers and barriers for the use of COPD Web in order to change behavior.

    3 months after baseline

Study Arms (2)

COPD Web

EXPERIMENTAL

Participants randomised to experimental group will be introduced to the COPD Web by a letter containing written information. All participants will receive a pedometer and written information about the importance of physical activity.

Behavioral: COPD Web

Control

NO INTERVENTION

Other than receiving a pedometer and written information about the importance of physical activity the patients in the control group will not receive any intervention.

Interventions

COPD WebBEHAVIORAL

The COPD Web will be introduced to the participant randomized to intervention by a letter containing a code to get access to the web site and how to create an account and login. At the web site there will be an instruction movie showing/ discussing specific content on the COPD Web. The web site will be self-managed. To secure that there is no technical or user problems participants will be contacted by a researcher the first week of intervention. Participants will receive "push notifications" (email) with targeted information containing links to the COPD Web and reminder to register the number of steps walked during that week. The push notifications will come every week (week 1-12), every other week (week 12 to 24) and every fourth week (week 24-52).

COPD Web

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All persons with a diagnosis of COPD (ICD-10:J44:9) who visit included primary care units due to their COPD.
  • Needs to understand and read Swedish.
  • Needs to have a smartphone, tablet or computer with access to internet.
  • In case of exacerbation, the participant has to wait at least 6 weeks after initiated pharmacological treatment, before being eligible in the study.

You may not qualify if:

  • Not COPD
  • Dementia or other psychiatric condition that can prevent understanding of the intervention.
  • Serious comorbidity that can be considered as the contributing factor for limitation in physical activity.
  • Has an account on the COPD Web.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Umeå university

Umeå, Sweden

Location

Related Publications (1)

  • Stenlund T, Nyberg A, Lundell S, Wadell K. Web-based support for self-management strategies versus usual care for people with COPD in primary healthcare: a protocol for a randomised, 12-month, parallel-group pragmatic trial. BMJ Open. 2019 Oct 7;9(10):e030788. doi: 10.1136/bmjopen-2019-030788.

    PMID: 31594889BACKGROUND

Related Links

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Karin Wadell, PhD

    Umeå University

    PRINCIPAL INVESTIGATOR
  • Tobias Stenlund, PhD

    Umeå University

    STUDY DIRECTOR
  • André Nyberg, PhD

    Umeå University

    STUDY DIRECTOR
  • Sara Lundell, MSc

    Umeå University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 15, 2018

First Posted

November 20, 2018

Study Start

November 15, 2018

Primary Completion

June 8, 2022

Study Completion

June 8, 2022

Last Updated

December 8, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations